October 2013 Newsletter

October 18, 2013:

Gusher of New Technology Spotlighted at 2013 ESCRS Meeting in Amsterdam

The annual gathering showcased an outstanding venue in Amsterdam, and attendance was up.

October 18, 2013:

US IOL Procedures Climb 4.1 Percent in Q2-2013

The rate was slightly higher than long-term trends.

October 18, 2013:

ASCRS Says Latest Compounding Bill Needs Work

A compromise version worked out by the House and Senate has dropped language referring to the repackaging of drugs.

October 18, 2013:

No Delay of Medical Device Tax For Now

The proposal was left out of a last-minute deal that ended the latest government shutdown.

October 18, 2013:

FDA Advisory Panel Backs ReSure Sealant

The sealant received a generally favorable review, though the vote reflected concerns over wording in the proposed indication.

October 18, 2013:

FDA Rules on Mobile Medical Apps, Identifying Medical Devices

With mobile medical apps, the agency said it plans to focus its oversight on those that are intended to be used as an accessory to a regulated medical device or that transform a mobile platform into a regulated medical device.

October 18, 2013:

Bausch + Lomb Sues Vitamin Health in Patent Infringement Case

Vitamin Health Inc. sells a range of products under the Viteyes brand that are based on the AREDS and AREDS 2 recommendations.

October 18, 2013:

October 2013 News Briefs

October 18, 2013:

Market Scope Provides Discount to Ophthalmology Innovation Summit

The meeting provides a forum for addressing key issues impacting the ophthalmic field and a platform for showcasing the most promising private ophthalmic companies.

October 18, 2013:

Come by Our Booth at the AAO Meeting in November

Social media